Insight Molecular Diagnostics Inc.

IMDX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2021

Total Assets: $159.6M

Liabilities Breakdown FY2021

Total Liabilities: $94.3M